Early Identification of Acute Pulmonary Embolism Identified with EarlySense Technology Presented in Clinical Poster Presentation
WOBURN, Massachusetts, May 20, 2020 /PRNewswire/ — EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced that JAMDA – The Journal of Post Acute and Long-Term Care Medicine has published the case report Early Identification of Acute Pulmonary Emboli Through the Use of Contact-Free Continuous Patient Monitoring. The report includes findings from a case study at Hebrew Home of Riverdale by RiverSpring Health showing that skilled nursing facilities (SNFs) incorporating contact-free, continuous patient monitoring (CFCM) can potentially aid in the early identification of acute changes in patient deterioration and rapid life-threatening treatment interventions.
The clinical poster was also presented at AMDA – The Society for Post-Acute and Long-Term Care Medicine’s 2020 Annual Conference, held virtually from April 2-5 2020.
“SNFs are faced with providing care for residents with increasing clinical complexity as residents are being discharged from hospitals to post-acute care earlier, and with multiple active co-morbidities,” said poster author Dr. Zachary Palace, Medical Director at the Hebrew Home of Riverdale by RiverSpring Health. “In this case study, the Hebrew Home clinical team was able to use continuous monitoring data to be notified of an immediate change in patient condition and make informed and time critical clinical decisions about the patient’s care.”
In the case study, an 89-year-old male patient was admitted to a SNF for post-acute care following a hospital stay for pneumonia. During his recovery, the CFCM system alerted staff regarding an abnormal respiratory rate. Staff found the patient unresponsive and immediately initiated intravenous fluid therapy. The patient remained hypotensive and was emergently transferred to a hospital where he was diagnosed with bilateral pulmonary emboli. The patient successfully underwent pulmonary arteriography and catheter-directed thrombolysis, and afterwards was admitted to an intensive care unit for monitoring. Once medically stable, the patient returned to the SNF, where he completed his course of skilled rehabilitation and was afterwards successfully discharged home.
“EarlySense is on a global mission to raise the standard of patient care throughout the healthcare continuum via contact-free, continuous monitoring and predictive analytics,” said Matt Johnson, CEO of EarlySense. “Although continuous monitoring is not currently the standard of care in long term and post-acute facilities, this study demonstrates its potential to play a pivotal role in providing health practitioners with the data necessary to identify acute changes of condition before they become critical.”
EarlySense® is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals and post-acute care facilities, the EarlySense system assists caregivers in early detection of potential patient adverse events, including code blue events resulting from cardiac or respiratory arrest, patient falls, pressure ulcers, preventable ICU transfers and hospital readmissions. The EarlySense system captures critical information from the patient, alerting caregivers of potentially adverse events early on. The company has partnered with leading global technology companies including Hillrom, Philips, Welch Allyn, and Mitsui. EarlySense is based in Ramat Gan, Israel and Woburn, Massachusetts.